After thyroid surgery, the incidence and severity of coughing is important because it may cause serious complications, such as bleeding in the surgical field, laryngospasm, and cardiovascular disturbance. Several studies have shown that the single-dose of dexmedetomidine is effective for reducing cough and agitation during emergence from general anesthesia. To test the hypothesis that single-dose of dexmedetomidine combined with a low-dose remifentanil infusion during emergence from general anaesthesia could reduce coughing as good as high-dose remifentanil infusion, we will evaluate the efficacy on cough suppression and reduction of side effect of remifentanil using non-inferiority trial.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
168
single dose administration (0.5mcg/kg) 10 min before end of the surgery with maintain the infusion of remifentanil (TCI 1 ng/ml) until end of surgery
maintain the infusion of remifentanil until end of the surgery (TCI 2 ng/ml)
Gangnam severance hospital
Seoul, South Korea
Incidence of coughing during emergence from general anesthesia
Time frame: from 5min before extubation to 5min after extubation
side effect of remifentanil
comparison of the incidence of delayed awakening, post-operative nausea/vomiting, consumption of pain killer
Time frame: up to 1 day after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.